日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

INSIGHT抗逆转录病毒治疗策略时机(START)试验中的基线心血管风险

Soliman, E Z; Sharma, S; Arastéh, K; Wohl, D; Achhra, A; Tambussi, G; O'Connor, J; Stein, J H; Duprez, D A; Neaton, J D; Phillips, A

Assessment of arterial elasticity among HIV-positive participants with high CD4 cell counts: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

对CD4细胞计数高的HIV阳性参与者进行动脉弹性评估:一项INSIGHT抗逆转录病毒治疗策略时机(START)试验的子研究

Baker, J V; Engen, N W; Huppler Hullsiek, K; Stephan, C; Jain, M K; Munderi, P; Pett, S; Duprez, D

Changes in N-terminal pro-B-type natriuretic peptide and incidence of diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA).

N 末端 B 型利钠肽前体的变化与糖尿病发病率:动脉粥样硬化多民族研究 (MESA)

Sanchez O A, Duprez D A, Bahrami H, Peralta C A, Daniels L B, Lima J A, Maisel A, Folsom A R, Jacobs D R

The E3 ubiquitin ligase specificity subunit ASB2beta is a novel regulator of muscle differentiation that targets filamin B to proteasomal degradation.

E3泛素连接酶特异性亚基ASB2β是肌肉分化的一种新型调节因子,它将丝状蛋白B靶向蛋白酶体降解

Bello N F, Lamsoul I, Heuzé M L, Métais A, Moreaux G, Calderwood D A, Duprez D, Moog-Lutz C, Lutz P G